The Weekly Dose: FDA Peptide Review, Genomic Peptides, and Mitochondrial Signaling

This week brought significant developments in the peptide therapeutics landscape, with the FDA scheduling a pivotal advisory committee meeting that could reshape access to several key compounds. Simultaneously, new research continues to reveal the remarkable breadth of biological activity exhibited by seemingly simple peptides—from genomic modulation to mitochondrial signaling. The convergence of regulatory scrutiny and expanding scientific understanding marks a critical juncture for researchers, clinicians, and anyone interested in the cutting edge of peptide science.

The FDA scheduled a July advisory committee meeting to review BPC-157, TB-500, and five other peptides for potential return to legal compounding. Here's what the meeting actually means—and what it doesn't.
Read the full analysis → /blog/fda-pcac-july-2026-peptide-compounding-review

GHK-Cu isn't just a skincare ingredient. Genomic analysis shows it modulates over 4,000 human genes — and the research is exploding.
Read the full analysis → /blog/ghk-copper-peptide-gene-modulation-2025

A 16-amino acid peptide encoded by your mitochondrial DNA that mimics exercise, fights obesity in mice, and was banned by WADA in 2024 — before a single human trial.
Read the full analysis → /blog/mots-c-mitochondrial-exercise-mimetic-peptide

Looking ahead, the July FDA PCAC meeting will be a bellwether for the future of peptide compounding in the United States. Regardless of the outcome, the underlying science driving interest in compounds like BPC-157, TB-500, MOTS-c, and GHK-Cu shows no signs of slowing. As we continue to uncover the complex mechanisms through which these peptides interact with human biology—from gene expression pathways to mitochondrial function—the imperative for rigorous, accessible research tools becomes ever more clear.

You just read about BPC-157, DSIP, KPV, and 4 others—compounds with diverse mechanisms ranging from tissue repair to genomic modulation to mitochondrial signaling. The BioStack Generator lets you model how these peptides interact with your specific goals, dosing schedule, and individual biology. Whether you're exploring recovery pathways, cognitive enhancement, or metabolic optimization, you can simulate combinations and timelines in under two minutes. No guesswork, just evidence-based modeling.